WCN26-759 DUAL PANCREAS-KIDNEY TRANSPLANTATION AS A STRATEGY TO REDUCE KIDNEY TRANSPLANT WAITING TIME: A CASE REPORT FROM A PRE-TRANSPLANT EVALUATION CLINIC

Read full text Summarise with VIRAT
Authors: Issaree Bunyawannukul, Antoney Ferrey, Sirirat Anutrakulchai, Sorawis Ngaohirunpat, Natanon Chamnarnphol, Panchanit Yongkiatkan, Napat Wongmat, Nongnapas Assawamasbunlue, Wanprapit Noree, Kaninart Chartpattananan, Thanin Asawaroekwisoot, Sitta Suntrawanichakul
+3 more Nopavit Mohpichai, Jahnavi Mikkilineni, Ekamol Tantisattamo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Simultaneous pancreas–kidney (SPK) transplantation is an established treatment for patients with end-stage kidneydisease (ESkD) secondary to diabetes mellitus. While historically reserved for type 1 diabetes (T1D), growing evidence supports its use in carefully selected insulin-dependent type 2 diabetes (T2D) patients, with outcomes comparable to those in T1D. Beyond metabolic benefits, SPK provides allocation advantages: candidates are often transplanted sooner than those listed for kidney-alone, and donor kidneys in SPK are typically of higher quality, originating from younger donors without significant medical co-morbidities.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Organ Donation and Transplantation Transplantation: Methods and Outcomes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105793–105793
Publication date
25 March 2026
Language
EN